RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
27 Dezembro 2023 - 6:05PM
RxSight, Inc., an ophthalmic medical device company dedicated to
providing high-quality customized vision to patients following
cataract surgery, today announced plans to participate in the
upcoming J.P. Morgan Healthcare Conference.
RxSight’s management is scheduled to present on Wednesday,
January 10, 2024, at 3:00 p.m. Pacific Time / 6:00 p.m. Eastern
Time. Interested parties may access a live and archived webcast of
the presentation at: https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated
to providing high-quality customized vision to patients following
cataract surgery. The RxSight® Light Adjustable Lens system,
comprised of the RxSight Light Adjustable Lens® (LAL®), RxSight
Light Delivery Device (LDD™) and accessories, is the first and only
commercially available intraocular lens (IOL) technology that can
be adjusted after surgery enabling doctors to customize and deliver
high-quality vision to patients after cataract surgery. Additional
information about RxSight can be found at www.rxsight.com.
Company Contact:Shelley B. ThunenChief
Financial Officersthunen@rxsight.com
Investor Relations Contact:Oliver MoravcevicVP,
Investor Relationsomoravcevic@rxsight.com
RxSight (NASDAQ:RXST)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
RxSight (NASDAQ:RXST)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024